The MEK1/2 Inhibitor Pimasertib Enhances Gemcitabine Efficacy in Pancreatic Cancer Models by Altering Ribonucleotide Reductase Subunit-1 (RRM1)

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-15-0485
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

The MEK1/2 Inhibitor Pimasertib Enhances Gemcitabine Efficacy--Response

Clinical Cancer Research
Cancer ResearchOncology
2016English

RRM1 (Ribonucleotide Reductase M1)

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2011English

Structures of Eukaryotic Ribonucleotide Reductase I Define Gemcitabine Diphosphate Binding and Subunit Assembly

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2006English

A Single Conserved Residue Mediates Binding of the Ribonucleotide Reductase Catalytic Subunit RRM1 to RRM2 and Is Essential for Mouse Development

Molecular and Cellular Biology
Cell BiologyMolecular Biology
2015English

Fluvastatin Synergistically Enhances the Antiproliferative Effect of Gemcitabine in Human Pancreatic Cancer MIAPaCa-2 Cells

British Journal of Cancer
Cancer ResearchOncology
2005English

Fasting Cycles Potentiate the Efficacy of Gemcitabine Treatment in in Vitro and in Vivo Pancreatic Cancer Models

Oncotarget
Oncology
2015English

In Vitro and in Vivo Comparison of Gemcitabine and the Gemcitabine Analog 1-(2′-Deoxy-2′-Fluoroarabinofuranosyl) Cytosine (FAC) in Human Orthotopic and Genetically Modified Mouse Pancreatic Cancer Models

Molecular Imaging and Biology
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2017English

Physical Interaction Between Human Ribonucleotide Reductase Large Subunit and Thioredoxin Increases Colorectal Cancer Malignancy

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2017English

Curaxin CBL0137 Eradicates Drug Resistant Cancer Stem Cells and Potentiates Efficacy of Gemcitabine in Preclinical Models of Pancreatic Cancer

Oncotarget
Oncology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy